IL146941A0 - Somatostain agonists - Google Patents
Somatostain agonistsInfo
- Publication number
- IL146941A0 IL146941A0 IL14694100A IL14694100A IL146941A0 IL 146941 A0 IL146941 A0 IL 146941A0 IL 14694100 A IL14694100 A IL 14694100A IL 14694100 A IL14694100 A IL 14694100A IL 146941 A0 IL146941 A0 IL 146941A0
- Authority
- IL
- Israel
- Prior art keywords
- somatostain
- agonists
- somatostain agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14102899P | 1999-06-25 | 1999-06-25 | |
PCT/US2000/017401 WO2001000676A1 (en) | 1999-06-25 | 2000-06-23 | Somatostatin agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146941A0 true IL146941A0 (en) | 2002-08-14 |
Family
ID=22493842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14694100A IL146941A0 (en) | 1999-06-25 | 2000-06-23 | Somatostain agonists |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1189942A1 (en) |
JP (1) | JP4041311B2 (en) |
CN (1) | CN1367792A (en) |
AR (1) | AR024463A1 (en) |
AU (1) | AU770958B2 (en) |
BR (1) | BR0011919A (en) |
CA (1) | CA2377265A1 (en) |
CZ (1) | CZ20014534A3 (en) |
HU (1) | HUP0201696A3 (en) |
IL (1) | IL146941A0 (en) |
MX (1) | MXPA01013127A (en) |
PL (1) | PL352763A1 (en) |
RU (1) | RU2263677C2 (en) |
WO (1) | WO2001000676A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2328077T3 (en) * | 2001-03-06 | 2009-11-06 | The Administrators Of The Tulane Educational Fund | PROCEDURE FOR MODULATION OF THE PROLIFERATION OF MEDULAR THYROID CARCINOMA CELLS. |
WO2003057214A1 (en) | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
WO2008132737A1 (en) | 2007-04-30 | 2008-11-06 | Technion Research & Development Foundation Ltd. | Novel antimicrobial agents |
US20100173832A1 (en) * | 2007-04-30 | 2010-07-08 | Technion Research & Development Foundation Ltd. | Anticancerous polymeric agents |
CA2781402C (en) * | 2009-11-23 | 2017-03-21 | Palatin Technologies, Inc. | Melanocortin-1 receptor-specific cyclic peptides |
WO2011151782A1 (en) | 2010-06-02 | 2011-12-08 | Preglem Sa | A role for somatostatin to modulate initiation of follicular growth in the human ovary |
US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
WO2014144231A1 (en) * | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE14226T1 (en) * | 1981-12-24 | 1985-07-15 | Ciba Geigy Ag | CYCLIC OCTAPEPTIDES AND PHARMACEUTICAL PREPARATIONS THEREOF, AND PROCESSES FOR THE MANUFACTURE THE SAME AND THEIR USE. |
HU207104B (en) * | 1991-01-25 | 1993-03-01 | Biosignal Kutato Fejlesztoe Kf | Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds |
SK15096A3 (en) * | 1993-08-09 | 1996-07-03 | Biomeasure Inc | Therapeutic peptide derivatives and a method of their application |
AU728224B2 (en) * | 1996-12-04 | 2001-01-04 | Administration Of The Tulane Educational Fund, The | Somatostatin antagonists |
DE69812084T2 (en) * | 1997-05-01 | 2003-12-24 | Cedars Sinai Medical Center | METHOD FOR TREATING HYPERPROLACTINEMIA AND PROLACTINOMA |
EP0981364B1 (en) * | 1997-05-13 | 2006-03-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Method and compositions for treating hyperlipidemia |
ES2202864T3 (en) * | 1997-05-13 | 2004-04-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | AGOMISTS OF THE SOMATOSTATINE TO DECREASE BODY WEIGHT. |
ES2216290T3 (en) * | 1997-05-13 | 2004-10-16 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | SOMATOSTATIN AND AGOMISTS OF SOMATOSTATIN FOR THE TREATMENT OF INSENSITIVITY TO INSULIN AND SYNDROME X. |
-
2000
- 2000-06-23 IL IL14694100A patent/IL146941A0/en unknown
- 2000-06-23 JP JP2001506685A patent/JP4041311B2/en not_active Expired - Fee Related
- 2000-06-23 AU AU62000/00A patent/AU770958B2/en not_active Ceased
- 2000-06-23 HU HU0201696A patent/HUP0201696A3/en unknown
- 2000-06-23 PL PL00352763A patent/PL352763A1/en not_active Application Discontinuation
- 2000-06-23 MX MXPA01013127A patent/MXPA01013127A/en unknown
- 2000-06-23 BR BR0011919-9A patent/BR0011919A/en not_active Application Discontinuation
- 2000-06-23 CZ CZ20014534A patent/CZ20014534A3/en unknown
- 2000-06-23 RU RU2002101732/04A patent/RU2263677C2/en not_active IP Right Cessation
- 2000-06-23 WO PCT/US2000/017401 patent/WO2001000676A1/en active IP Right Grant
- 2000-06-23 EP EP00948520A patent/EP1189942A1/en not_active Ceased
- 2000-06-23 CN CN00811189A patent/CN1367792A/en active Pending
- 2000-06-23 AR ARP000103155A patent/AR024463A1/en unknown
- 2000-06-23 CA CA002377265A patent/CA2377265A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0201696A3 (en) | 2002-10-28 |
CN1367792A (en) | 2002-09-04 |
PL352763A1 (en) | 2003-09-08 |
MXPA01013127A (en) | 2002-11-04 |
AU770958B2 (en) | 2004-03-11 |
AU6200000A (en) | 2001-01-31 |
CA2377265A1 (en) | 2001-01-04 |
CZ20014534A3 (en) | 2002-06-12 |
WO2001000676A1 (en) | 2001-01-04 |
EP1189942A1 (en) | 2002-03-27 |
RU2263677C2 (en) | 2005-11-10 |
JP4041311B2 (en) | 2008-01-30 |
JP2003503369A (en) | 2003-01-28 |
AR024463A1 (en) | 2002-10-02 |
BR0011919A (en) | 2002-03-19 |
HUP0201696A2 (en) | 2002-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1023061A4 (en) | Somatostatin agonists | |
EP0977751A4 (en) | Somatostatin agonists | |
EP0984779A4 (en) | Somatostatin agonists | |
GB2346760B (en) | Earphone-microphone adapter | |
IL148218A0 (en) | New phenylpiperazines | |
GB9818914D0 (en) | Use | |
GB9913536D0 (en) | Use | |
IL145995A0 (en) | Use | |
GB9805486D0 (en) | Adapter | |
AU142489S (en) | Holder | |
IL146941A0 (en) | Somatostain agonists | |
GB0015517D0 (en) | Somatostatin agonists | |
GB2340521B (en) | Shale-stabilizing additives | |
HUP0004317A3 (en) | 5-ht1f agonists | |
IL144355A0 (en) | 5-ht1f agonists | |
GB9914798D0 (en) | Ensure | |
GB9828004D0 (en) | Use | |
GB9807503D0 (en) | Use | |
GB9919971D0 (en) | Use | |
GB9903377D0 (en) | Amphibious-tricycle (amphi-trike) | |
GB9929772D0 (en) | New use | |
GB9914445D0 (en) | Cradle | |
AU140373S (en) | Bumbag | |
GB9806697D0 (en) | Somatostatin agonists | |
GB9904877D0 (en) | Kounta -attak!!! |